pembrolizumab,quavonlimab,favezelimab,lenvatinib
eisai,merck
['s102']
patrick wen talking about the role of molecular profiling in neuro-oncology! please make your way over to s102 - the session happening now at 1:00 pm #asco2023 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.